MedicaidAdministrativeMedium impact
REMS Certification and Provider Training Required to Administer Nexplanon
Medi-Cal·CA · OB-GYN, Family Medicine, General Practice·Provider Bulletin
Effective date
Jan 16, 2026
We identified it
Jul 28, 2026
Summary
Effective January 16, 2026, the FDA extended Nexplanon® approval from 3 years to 5 years for pregnancy prevention. All providers performing Nexplanon insertions or removals must complete FDA-required REMS certification by August 23, 2026, or lose the ability to procure and insert the device. Billing teams must ensure provider credentials reflect current REMS enrollment status to avoid claim rejections.
Action Required
By August 23, 2026: Verify that all providers in your practice who insert or remove Nexplanon have completed FDA REMS certification and enrollment. Maintain documentation of REMS enrollment status in provider credentialing files. Contact Nexplanon REMS website (https://nexplanon.com/rems) to confirm enrollment for each provider. Billing team should flag any claims for Nexplanon insertion/removal (typically coded under family planning contraceptive services) from non-REMS-certified providers and reject them prior to submission. Update provider onboarding procedures to require REMS certification documentation before any Nexplanon procedures are billed. Failure to maintain current REMS certification will result in inability to legally procure and administer Nexplanon, rendering related claims unbillable.